They focus the immune system on the tumor by teaching it to identify some "neoantigens" in the tumor. Turns out that tumors express various strange proteins in their cell wall, I suppose because of the inherent genetic instability.
Anyone know why this can't be a silver bullet for most tumors? Like, a way to target an intrinsic characteristic of cancers that in theory could be very effective on most of them.. sounds too good to be true. So, what's the catch?
Anyone know why this can't be a silver bullet for most tumors? Like, a way to target an intrinsic characteristic of cancers that in theory could be very effective on most of them.. sounds too good to be true. So, what's the catch?